Kirkland & Ellis LLP represents Chicago-based private equity firm Madison Dearborn Partners in its definitive agreement announced today with Walgreen Co. to acquire a majority interest in Walgreens Infusion Services, one of the nation’s largest providers of home and alternate treatment site infusion services. Financial terms of the agreement were not disclosed. The transaction is subject to satisfaction of regulatory requirements and other conditions and is expected to close during the second quarter of calendar year 2015.
The Kirkland team includes corporate partners Sanford Perl and Mark Fennell, and associates Joshua Faulkner and Dan Hoppe, along with debt finance partners Michael Wright, Amy Peters and David Milligan, associates Brian Tweedie and Ryan Copeland, and capital markets partner Dennis Myers.
More information on the transaction is available here.